Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.
Related Posts
Bank of England holds interest rates, British pound rallies to more than two-year high
The decision to hold comes after the U.S. Federal Reserve kicked off its own monetary easing with an aggressive 50…
LA police enforce curfew as Trump vows to ‘liberate’ city
Police in the city say they have made mass arrests, as a war of words between the president and California’s…
Trump ‘an agent of chaos and confusion,’ economists warn — but a U.S. recession isn’t in the cards yet
Economists say Trump is proving to be an “agent of chaos” with his unpredictable trade tariff policies but a downturn…